1801.HK 財務： Innovent Biologics, Inc. AI 分析

Q: 技術分析指標如何適用於 1801.HK？

根據技術分析，Innovent Biologics, Inc. 的綜合信號為 Buy。Innovent Biologics, Inc. 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 1801.HK 的費波那契回檔水準是多少？

Innovent Biologics, Inc. 的費波那契回檔水準是 高於 0% 水準。

Q: Innovent Biologics, Inc. 的 RSI 是多少？

Innovent Biologics, Inc. 的 RSI 目前為 69.96，表明處於 中立 狀態

Q: Innovent Biologics, Inc. 接下來 12 個月的價格是多少？

Innovent Biologics, Inc. 1801.HK 接下來 12 個月的價格預估為 $107.55。

Q: Innovent Biologics, Inc. 預計會漲到多高？

據華爾街分析師稱，Innovent Biologics, Inc. 預計將達到 $144.27 的高預測值。

首頁

股票

1801.HK

預測

INNOVENT BIO (1801.HK)

Innovent Biologics, Inc.

HK$84.7

-3.96%

$-3.5

盤中： Jan 19, 13:34:15 HKT

關鍵數據

前收市價

$89.5

開盤價

$88.2

當日範圍

$83.6 - $89.35

52週區間

$30.75 - $109.1

交易量

8.5M

平均成交量

14.1M

每股盈餘 (TTM)

0.74

股息收益率

市值

$145.7B

什麼是 INNOVENT BIO？

Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 1801.HK in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $107.55. The lowest target is $40.4 and the highest is $144.27. Empower your investment choices with our cutting-edge, data-driven analysis!

1801.HK 股價預測摘要

1801.HK 的頂級分析師評級

根據 36 位分析師對 1801.HK 的股票評級，更新於 Jan 01, 2026

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for 1801.HK. Our analysts highlight strong fundamentals and favorable market sentiment, positioning 1801.HK for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: 1801.HK is a Strong Buy candidate.

1801.HK stock price ended at $89.5 on 星期五, after rising 0.56%

On the latest trading day Jan 16, 2026, the stock price of 1801.HK rose by 0.56%, climbing from $89.05 to $89.50. Throughout the session, the stock experienced a volatility of 2.38%, with prices fluctuating between a daily low of $88.35 and a high of $90.45. Alongside this price increase, trading volume also rose by 4.7M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 6.7M shares were traded, amounting to a market value of approximately $154.0B.

1801.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

1801.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 0.56%。整體而言，技術指標顯示中期後市趨勢為 Buy。

1801.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為1801.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 1801.HK？



1801.HK 的費波那契回檔水準是多少？



Innovent Biologics, Inc. 的 RSI 是多少？



Innovent Biologics, Inc. 接下來 12 個月的價格是多少？



Innovent Biologics, Inc. 預計會漲到多高？



Innovent Biologics, Inc.（1801.HK）價格

1801.HK 股價走勢圖